184 related articles for article (PubMed ID: 10820269)
21. Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis.
Morris-Wiman J; Du Y; Brinkley L
J Craniofac Genet Dev Biol; 1999; 19(4):201-12. PubMed ID: 10731089
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
23. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Baldini E; Toller M; Graziano FM; Russo FP; Pepe M; Biordi L; Marchioni E; Curcio F; Ulisse S; Ambesi-Impiombato FS; D'Armiento M
Thyroid; 2004 Nov; 14(11):881-8. PubMed ID: 15671765
[TBL] [Abstract][Full Text] [Related]
25. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C-mediated regulation of matrix metalloproteinase and tissue inhibitor of metalloproteinase production in a human retinal müller cells.
Miyata Y; Kase M; Sugita Y; Shimada A; Nagase T; Katsura Y; Kosano H
Curr Eye Res; 2012 Sep; 37(9):842-9. PubMed ID: 22667460
[TBL] [Abstract][Full Text] [Related]
27. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.
El Fahime E; Torrente Y; Caron NJ; Bresolin MD; Tremblay JP
Exp Cell Res; 2000 Aug; 258(2):279-87. PubMed ID: 10896779
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 alpha alters the expression of matrix metalloproteinases and collagen degradation by pulp fibroblasts.
Wisithphrom K; Murray PE; Windsor LJ
J Endod; 2006 Mar; 32(3):186-92. PubMed ID: 16500223
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
Ogasawara S; Yano H; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Kojiro M
Oncol Rep; 2005 Jun; 13(6):1043-8. PubMed ID: 15870919
[TBL] [Abstract][Full Text] [Related]
30. MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels.
Koike T; Vernon RB; Hamner MA; Sadoun E; Reed MJ
J Cell Biochem; 2002; 86(4):748-58. PubMed ID: 12210741
[TBL] [Abstract][Full Text] [Related]
31. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
Pan CH; Wen CH; Lin CS
Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
[TBL] [Abstract][Full Text] [Related]
32. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
Zhou J; Windsor LJ
J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
Pohl M; Sakurai H; Bush KT; Nigam SK
Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials.
Jones JA; McNally AK; Chang DT; Qin LA; Meyerson H; Colton E; Kwon IL; Matsuda T; Anderson JM
J Biomed Mater Res A; 2008 Jan; 84(1):158-66. PubMed ID: 17607751
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases and their inhibitors in oral lichen planus.
Zhou XJ; Sugerman PB; Savage NW; Walsh LJ
J Cutan Pathol; 2001 Feb; 28(2):72-82. PubMed ID: 11168755
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
[TBL] [Abstract][Full Text] [Related]
38. The expression of matrix metalloproteinases and their inhibitors in corneal fibroblasts by alarmins from necrotic corneal epithelial cells.
Iwatake A; Murakami A; Ebihara N
Jpn J Ophthalmol; 2018 Jan; 62(1):92-100. PubMed ID: 29094325
[TBL] [Abstract][Full Text] [Related]
39. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
